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Abstract
Background:  Interstitial cystitis (IC) is a chronic bladder disorder of unknown etiology.
Antiproliferative factor (APF), a peptide found in the urine of IC patients, has previously been
shown to decrease incorporation of thymidine by normal bladder epithelial cells. This study was
performed to determine the effect of APF on the cell cycle of bladder epithelial cells so as to better
understand its antiproliferative activity.
Methods: Explant cultures from normal bladder biopsy specimens were exposed to APF or mock
control. DNA cytometry was performed using an automated image analysis system. Cell cycle
phase fractions were calculated from the DNA frequency distributions and compared by two-way
analysis of variance (ANOVA).
Results: APF exposure produced statistically significant increases in the proportion of tetraploid
and hypertetraploid cells compared to mock control preparations, suggesting a G2 and/or M phase
cell cycle block and the production of polyploidy.
Conclusions: APF has a specific effect on cell cycle distributions. The presence of a peptide with
this activity may contribute to the pathogenesis of interstitial cystitis through disruption of normal
urothelial proliferation and repair processes.
Background
Interstitial cystitis (IC) is a chronic bladder disorder pre-
senting with long-term symptoms of round-the-clock uri-
nary frequency and/or pain in the absence of any other
reasonable causation [1]. Although there are multiple
hypotheses on the primary cause of IC [2-7], it remains a
clinical enigma since there are no definitive data to sup-
port these theories [2-7]. A recent breakthrough in IC
research has been the discovery of antiproliferative factor
(APF) and its association with IC [8]. APF, a peptide puri-
fied from the urine of IC patients has been shown to
decrease incorporation of thymidine by bladder epithelial
cells, decrease levels of urinary heparin-binding epider-
mal growth factor-like growth factor (HB-EGF) and
increase levels of epidermal growth factor (EGF) in vitro
which reflects altered levels of these growth factors seen in
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IC patients [9,10]. Studies to characterize APF at the
molecular level are on-going. To date, the activity corre-
sponds to a single HPLC peak which contains a peptide
with a molecular weight less than 3,000 Dalton [10].
Additionally, urine APF activity is found at a higher level
in IC vs. non-IC patients [11]. APF is a reliable marker of
IC and may be an important factor in the pathogenesis of
IC [12]. This study was performed to determine the effect
of APF on the cell cycle of bladder epithelial cells so as to
better understand its antiproliferative activity.
Methods
Patients
The IC patient was a 28 year old white male who had pre-
viously undergone cystoscopy and fulfilled the National
Institute of Diabetes, Digestive, and Kidney Diseases
(NIDDK) diagnostic criteria for IC which included
glomerulations upon cystoscopic examination as well as
urgency and dysuria. The control was a 41 year old white
female with no history of urinary tract pathology under-
going pelvic surgery. Informed consent was obtained from
both subjects in accordance with guidelines of the Institu-
tional Review Board of the University of Maryland School
of Medicine.
Explant specimen procurement
Cystoscopy was performed with the patient under general
anesthesia using non bacteriostatic normal saline as a
bladder irrigant. Rigid cold cup biopsy forceps were used
to acquire 4 mm2 pieces of transitional epithelium with
submucosa for growth of primary bladder epithelial cells.
Tissue specimens were transported from the operating
room in sealed sterile containers containing sterile phos-
phate buffered saline (PBS, Biosource International.
Camarillo, CA) at room temperature, removed and placed
in DMEM-F12 (Cellgro, Herndon, VA) containing 10%
fetal bovine serum, 1% antibiotic/antimycotic solution,
1% glutamine, 5 µg/ml EGF and 1 U/ml insulin (all from
Sigma, St. Louis, MO), for growth of bladder epithelial
cell explants, characterized by binding of AE-1/AE-3 pan-
cytokeratin antibodies as previously described [13].
Antiproliferative Factor
APF was prepared from the supernatant of bladder epithe-
lial cells explanted from one IC patient and purified using
molecular weight fractionation, ion exchange chromatog-
raphy, hydrophobic interaction chromatography, and
reversed phase high performance liquid chromatography
(HPLC), as previously described [10]. Mock preparations
from culture media of cells from the non-IC control
patient were processed using the same purification proce-
dure. Mock preparations do not have any HPLC detecta-
ble peptide.
APF treatment
Normal bladder cell explant cultures were plated at 1 ×
104 cells per well of a 6 well tissue culture plate in Eagle's
minimal essential medium (MEM, Invitrogen, Carlsbad,
CA) containing 10% fetal bovine serum, 1% antibiotic/
antimycotic solution (Sigma, St. Louis, MO) 1%
glutamine and incubated overnight at 37°C in a 5% CO2
atmosphere. The following day, cells were serum starved
(MEM containing 1% glutamine and 1% antibiotic/
antimycotic solution) and incubated overnight at 37°C.
On the third day, HPLC-purified APF or mock preparation
(10, 20, and 50 µl) was added to the medium and cells
were further incubated at 37°C for 48 hours. On day 5,
cells were harvested (trypsin/EDTA) and pelleted at 1000
× g centrifugation, resuspended in PBS and fixed using
95% ethanol while vortexing at low speed. Samples were
then stored at 4°C until used.
DNA cytometry
All specimens were cytocentrifuged onto slides using a
CytoTek Cytocentrifuge at 1,000 RPM for 5 minutes, fixed
in 10% Böhm-Springer fixative, hydrolyzed for 45 min-
utes in 5 N hydrochloric acid and the DNA stained by
Feulgen reaction using thionin according to Perceptronix
Medical Incorporated (PMI) standard protocol. The Fuel-
gen stained nuclei were analyzed on a PMI Cytosavant
image analysis instrument, which was programmed to
scan each slide and acquire 2,000 single nuclei. Debris
and cell clumps were rejected using optical density and
morphometric features. DNA content was calculated from
sum optical density. Diploid control cells were used for
validation and identification of G1 cell populations for
normalization. Morphometric features for selecting sin-
gle, whole nuclei included area, sphericity, and eccentric-
ity. After acquisition, cell image galleries were reviewed to
ensure that only data from whole, single nuclei were
retained in the frequency distribution file. The frequency
and cumulative frequency of nuclei were plotted for the
calculated sum optical density (DNA content) (Figures 1
and 2). The boundaries of the cell cycle phases were iden-
tified by the inflection points in the cumulative frequency
distribution and cell subpopulation fractions were
calculated.
Statistical analysis
ANOVA analysis was performed using Statview (SAS Insti-
tute, Cary, North Caroline) with cell cycle fractions
dependence on the independent variables treatment (APF
or Mock) and dose (volume of treatment).
Results
Primary cultures of normal bladder epithelium were
treated in replicate with 10, 20 or 50 µl of APF or mock
preparation per 3 ml well. DNA histograms from one rep-
licate of APF treated (10 µl) and one mock treated sampleBMC Urology 2004, 4 http://www.biomedcentral.com/1471-2490/4/3
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are presented in Figure 1. The histograms clearly show that
APF treatment increased the proportion of cells with tetra-
ploid DNA values. There is also a distinct population of
cells at the octaploid level. Cell cycle analysis from DNA
frequency distributions is relatively straightforward when
dealing with a cycling diploid population. The presence of
what appears to be a significant cycling tetraploid popula-
tion in the APF treated cells complicates the analysis.
While there are sophisticated algorithms for estimating
the cell cycle phases for each of two populations they are
largely built on the assumption that the two populations
are independent. To determine whether APF may contrib-
ute to the formation of tetraploid cells by producing a G2
or M phase block of the cell cycle for both diploid and
tetraploid cells, the DNA frequency distributions for all
samples were analyzed to extract the proportion of cells
with diploid, diploid S, tetraploid, tetraploid S, and octa-
ploid DNA values. Cumulative frequency distributions
were calculated and then plotted (Figure 2). Cell sub-pop-
ulations were derived from these cumulative frequency
distributions.
Cell population fractions for all samples appear in Table
1. As presented, the sum of all fractions is 100% and an
increase in the percentage of cells in one group due to
treatment will reduce the percentage in other groups. Dip-
loid percentages are lower for APF treated samples than
for Mock treated samples at all treatment levels. ANOVA
analysis (STATVIEW Statistical Analysis software) of the
effect of treatment as a factor and dose as a covariate on
the diploid percentage yielded p-values of less than
0.0001 for both. Similarly there were statistically signifi-
cant increases in Diploid S (p = 0.0041), Tetraploid (p =
0.0005), Tetraploid S (p = 0.0015), and Octaploid (p =
0.0098) fractions. Dose was significant only for the
decrease in the Diploid population and an increase in the
Tetraploid fraction (p < 0.0001). Little difference was seen
between the 10 and 20 µl doses for either Mock or APF
treated samples, but cells treated with 50 µl of APF or the
mock preparation were clearly different from the lower
level treatments. This experiment has been replicated five
times with similar results.
Discussion
Interstitial cystitis is a chronic bladder disease that,
although first described during the 19th century, today still
has no certain etiologies, no specific pathology, and no
predictably effective treatment or cure [14]. Hypotheses as
to the causes of interstitial cystitis include infection, uri-
nary toxins, increased epithelial permeability, mast cell
involvement, neurogenic mechanisms, autoimmune or
genetic abnormalities, or a combination of these [2-7].
However, no studies to date have effectively proven any of
these mechanisms.
Representative DNA frequency distributions Figure 1
Representative DNA frequency distributions DNA 
frequency distributions from 10 µl mock treated (top panel) 
and 10 µl APF treated (bottom panel) normal bladder epithe-
lial cell cultures show an APF associated increase in the pro-
portion of cells with tetraploid DNA value. The presence of 
cells with octaploid DNA values suggests the cultures con-
tain a mixture of cycling diploid and tetraploid cells.
Cumulative DNA frequency distributions Figure 2
Cumulative DNA frequency distributions Cumulative 
DNA frequency distributions for 10 µl mock treated (red 
line) and 10 µl APF (blue line) treated normal bladder epithe-
lial cells were used to calculate cell cycle sub-population 
fractions.BMC Urology 2004, 4 http://www.biomedcentral.com/1471-2490/4/3
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A recent breakthrough for interstitial cystitis has been the
discovery of antiproliferative factor [8]. In addition to
decreased tritiated thymidine incorporation by bladder
epithelial cells treated with APF, explanted bladder epithe-
lial cells from IC patients produce APF, have decreased
proliferation, and produce significantly less HB-EGF than
bladder cells from controls. Addition of HB-EGF to cell
media can overcome the effects of APF on bladder epithe-
lium and cell proliferation [10,11]. Finally, Chai et al
showed that urine APF activity decreases while HB-EGF
levels normalize in IC patients following two different IC
therapies: bladder hydrodistension [14] and 3rd sacral
nerve root stimulation [15]. These findings suggest the
intriguing possibilities that bladder epithelial abnormali-
ties in IC may be caused by APF, and that replacement of
specific factor(s) altered by APF (such as HB-EGF) may
result in normalization of bladder epithelial cell growth
[16].
However, the mechanism for APF's action is unclear. It is
hypothesized that IC symptoms exacerbate following
bladder epithelial damage due to an acute sloughing of
epithelial cells. The presence of APF in the urine inhibits
appropriate epithelial cells regeneration by regulating
autocrine HB-EGF and cell adhesion protein production,
resulting in thinning or denudation of the bladder epithe-
lium in IC patients [16].
The goal of the study was to help in the elucidation of
APF's mechanism of action. Our primary conclusion from
these data is that APF has a profound impact on cell cycle
distributions. APF treated cells increase the proportion of
cells in the G2M phase, which is likely due to a G2/M
block.
Another possible effect of APF that might lead to changes
in the bladder epithelia is the production of polyploidy.
The appearance of polyploidy is not uncommon in tissue
culture and even normal tissue [18,19]. Polyploidy may
result from cellular and then nuclear fusion, or conceiva-
bly through mitosis in which cellular DNA is replicated
but mitosis and/or cytokinesis fail to occur. Cellular
fusion is not uncommon and is even part of normal func-
tion in some cell types. After cellular fusion, nuclear
fusion probably requires synchronous mitosis, fusion of
the mitotic spindle producing two tetraploid daughter
cells. This could in turn affect epithelial regeneration as is
hypothesized to occur in IC patients. Future studies are
needed to help address this issue and to determine if this
polyploidy has any significance in APF's mechanism or IC
development, or whether it is an unrelated in vitro phe-
nomenon.
The primary bladder epithelial cells used in these experi-
ments were treated with APF or Mock preparations in
serum free media. Unlike many other cell types, the lack
of exogenous growth factors does not produce a cell cycle
blockade. The cells produce sufficient autocrine signaling
to maintain a population in a proliferative state, and
therefore serum starvation is insufficient to produce cell
cycle blockade. Study of synchronized cell populations
will greatly facilitate investigation of the mechanism of
APF mediated cell cycle changes.
Table 1: Cell population fractions (%). Cumulative frequency distributions were examined to extract cell cycle and ploidy sub-
populations. Diploid fraction corresponds to a DNA normal 2C non-cycling DNA content. Diploid S fractions have DNA content 
between diploid and tetraploid values. The tetraploid sub-population contains both diploid G2/M cells and tetraploid G1 cells. The cells 
with DNA content between tetraploid and octaploid are S-phase tetraploid cells, Octaploid DNA content cells are the G2/M cells of the 
tetraploid population.
Treatment Dose (µl) Diploid Diploid S Tetraploid Tetraploid S Octaploid
APF 10 57.27 8.72 28.76 1.54 3.72
APF 10 58.87 3.88 32.26 1.18 3.81
APF 20 58.82 4.80 30.78 1.18 4.43
APF 20 58.17 8.44 30.02 1.07 2.31
APF 50 40.11 2.23 51.40 0.56 5.71
APF 50 34.89 4.68 54.24 1.08 5.11
Mock 10 87.72 1.64 9.60 0.50 0.55
Mock 10 90.14 1.83 7.13 0.25 0.64
Mock 20 90.60 2.05 6.77 0.34 0.24
Mock 20 91.14 1.47 6.80 0.15 0.44
Mock 50 73.08 5.98 20.75 0.00 0.19
Mock 50 72.45 5.85 20.22 0.40 1.09Publish with BioMed Central    and   every 
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There was an unexpected increase in the proportion of
cells with tetraploid DNA content at the highest mock
dose. This may be due to the acetonitrile and/or TFA used
in the high performance liquid chromatography (HPLC)
preparation. There may be a low level of APF in the mock
preparation, but no decrease in tritiated thymidine has
been observed in similarly controlled experiments, nor
can any APF be detected by UV absorbance in the HPLC.
Both preparations had equivalent amounts of ace-
tonitrile/TFA so as to control for any affect that these two
substances might have on the cells.
Conclusions
Antiproliferative factor has been shown to be a specific
protein associated with interstitial cystitis, although its
role in the pathogenesis of IC remains unknown. This
study shows that APF modulates the cell cycle and in fact
might lead to G2 blockade or the production of poly-
ploidy. This would in effect prevent regeneration of blad-
der epithelial cells, therefore possibly causing the
epithelial thinning and/or ulceration associated with IC.
Greater understanding of APF's mechanism of action
could aid in the diagnoses and treatment of interstitial
cystitis.
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